Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase 2/3 1Phase 1/2 1

Status

Completed 15Recruiting 9Unknown 5Terminated 5Active not recruiting 5Withdrawn 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Relapsed Pediatric Solid Tumor 1Lung Adenocarcinoma Metastatic 1Gallbladder Neoplasms 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Crizotinib × Clear all
NCT03574402 2022-12-06

TRUMP

Guangdong Association of Clinical Trials

Phase 2 Unknown
400 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02638428 2020-03-19

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Samsung Medical Center

Phase 2 Unknown
90 enrolled
Other solid neoplasm

Relapsed Pediatric Solid Tumor

NCT02836847 2018-05-07

Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown
152 enrolled
Gastrointestinal

Gallbladder Neoplasms

NCT02499614 2017-10-25

METROS

Fondazione Ricerca Traslazionale

Phase 2 Unknown
80 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02946359 2016-11-02

A+C in Metastatic Lung Adenocarcinoma Cancer

Chinese PLA General Hospital

Phase 2 Unknown
60 enrolled

Lung Adenocarcinoma Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡